HCG Outlines Growth Roadmap with Focus on Expansion, Efficiency and Clinical Excellence

Healthcare Global Enterprises Limited (HCG), India’s largest dedicated oncology platform, presented its strategic growth plan at an investor meet on December 4, 2025. CEO Dr. Manish Mattoo highlighted the company’s leadership across 25 hospitals in 19 cities, with a bed capacity of 2,500+ and the country’s largest LINAC fleet (38 units). The company achieved a 15% revenue CAGR to over ₹2,200 crore and 18% EBITDA CAGR to ₹396 crore in FY25, underpinned by clinical excellence—evidenced by an industry-leading gross mortality rate of 0.90%. HCG’s four-pillar strategy focuses on network optimization, strategic expansion, operational efficiency, and digital transformation. Existing facilities are currently operating at only 50–60% of revenue potential, offering significant upside through improved occupancy and payor mix (targeting higher cash/insurance share). Operations are now organized into regional clusters: West: ₹990 crore revenue (17% CAGR) South: ₹875 crore (13% CAGR) East: ₹255 crore (26% CAGR) International: ₹43 crore from Kenya Financially, HCG has strengthened its balance sheet, reducing net debt/EBITDA from 6.2x (FY20) to 2.3x (FY25) and generating ₹754 crore in operating cash flow over five years. It plans ₹600–700 crore capex over 2–3 years to add 1,000 beds via brownfield and greenfield expansions in cities like Pune, Surat, and Varanasi. With targets of 21–22% EBITDA margins and 20%+ ROCE within 3–5 years, HCG is poised for scalable, profitable growth—reinforcing its position as India’s premier cancer care provider.